Home > Insider Trading > Filing (0001140361-15-005042)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238403	K Daniel Spiegelman	105 Digital Drive Novato CA 94949	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-03-18	7	$61.48	68,683	No	4	A	Direct
Common Stock	Acquisiton	2013-03-18	7	$61.38	68,690	No	4	A	Direct
Common Stock	Acquisiton	2013-03-20	5	$61.99	68,695	No	4	A	Direct
Common Stock	Acquisiton	2013-03-20	4	$61.43	68,699	No	4	A	Direct
Common Stock	Acquisiton	2013-06-19	9	$58.57	68,708	No	4	A	Direct
Common Stock	Acquisiton	2013-06-19	9	$58.85	68,717	No	4	A	Direct
Common Stock	Acquisiton	2013-09-10	8	$70.06	68,725	No	4	A	Direct
Common Stock	Acquisiton	2013-09-10	7	$70.30	68,732	No	4	A	Direct
Common Stock	Acquisiton	2013-10-04	5	$74.07	68,737	No	4	A	Direct
Common Stock	Acquisiton	2013-10-07	6	$74.84	68,743	No	4	A	Direct
Common Stock	Acquisiton	2013-10-30	4	$66.48	68,747	No	4	A	Direct
Common Stock	Acquisiton	2013-10-30	5	$65.75	68,752	No	4	A	Direct
Common Stock	Acquisiton	2013-11-20	8	$65.89	68,760	No	4	A	Direct
Common Stock	Disposition	2014-03-05	12	$82.93	68,748	No	4	S	Direct
Common Stock	Disposition	2014-05-02	3	$58.02	68,745	No	4	S	Direct
Common Stock	Disposition	2014-05-02	8	$58.78	68,737	No	4	S	Direct
Common Stock	Acquisiton	2014-08-06	7	$62.17	68,744	No	4	A	Direct
Common Stock	Acquisiton	2014-08-06	7	$62.18	68,751	No	4	A	Direct
Common Stock	Disposition	2014-09-03	9	$69.83	68,742	No	4	S	Direct
Common Stock	Disposition	2014-09-03	9	$69.70	68,733	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Inadvertent transaction not directed by the reporting person through a broker-administered investment pool.
Some of the transactions executed as reported herein resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"). The Reporting Person has made arrangements with the Issuer to disgorge short swing profits realized to the Issuer, and upon settlement, the Reporting Person will have discharged in full any obligation under Section 16(b) with respect to the reported transactions.